Lois Chandler, Ph.D.
Chief Operating Officer
Dr. Chandler has served as Chief Operating Officer of Gene Biotherapeutics since July 2019 and previously served as Vice President, Product Development of Gene Biotherapeutics, and its subsidiary, Activation Therapeutics (2006-2019). Dr. Chandler is the inventor of the FDA-cleared Excellagen wound care product, developed by Activation Therapeutics. Dr. Chandler received a B.S. in Chemistry from Stanford University, Palo Alto, CA, and a Ph.D. in Biochemistry from the University of Southern California.